Tumor necrosis factor induces pathogenic mitochondrial ROS in tuberculosis through reverse electron transport

Science. 2022 Jun 24;376(6600):eabh2841. doi: 10.1126/science.abh2841. Epub 2022 Jun 24.

Abstract

Tumor necrosis factor (TNF) is a critical host resistance factor against tuberculosis. However, excess TNF produces susceptibility by increasing mitochondrial reactive oxygen species (mROS), which initiate a signaling cascade to cause pathogenic necrosis of mycobacterium-infected macrophages. In zebrafish, we identified the mechanism of TNF-induced mROS in tuberculosis. Excess TNF in mycobacterium-infected macrophages elevates mROS production by reverse electron transport (RET) through complex I. TNF-activated cellular glutamine uptake leads to an increased concentration of succinate, a Krebs cycle intermediate. Oxidation of this elevated succinate by complex II drives RET, thereby generating the mROS superoxide at complex I. The complex I inhibitor metformin, a widely used antidiabetic drug, prevents TNF-induced mROS and necrosis of Mycobacterium tuberculosis-infected zebrafish and human macrophages; metformin may therefore be useful in tuberculosis therapy.

MeSH terms

  • Animals
  • Citric Acid Cycle / drug effects
  • Electron Transport
  • Electron Transport Complex I* / antagonists & inhibitors
  • Electron Transport Complex I* / metabolism
  • Humans
  • Macrophages* / metabolism
  • Macrophages* / microbiology
  • Macrophages* / pathology
  • Metformin* / pharmacology
  • Mycobacterium tuberculosis* / metabolism
  • Necrosis
  • Reactive Oxygen Species* / metabolism
  • Succinic Acid / metabolism
  • Tuberculosis* / metabolism
  • Tuberculosis* / microbiology
  • Tuberculosis* / pathology
  • Tumor Necrosis Factor-alpha* / metabolism
  • Zebrafish

Substances

  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • Metformin
  • Succinic Acid
  • Electron Transport Complex I